Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.
[1] Austin G Duffy, et al. J Hepatol. 2017 Mar;66(3):545-551.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥1,710.00 | 现货 | 1 | |
| 5mg | ¥5,130.00 | 现货 | 1 | |
| 10mg | ¥7,650.00 | 现货 | 1 |
















Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.
[1] Austin G Duffy, et al. J Hepatol. 2017 Mar;66(3):545-551.